carbamates has been researched along with cannabidiol in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drysdale, AJ; Pertwee, RG; Platt, B; Ryan, D | 1 |
| Limebeer, CL; Mechoulam, R; Parker, LA; Piomelli, D; Rock, EM | 1 |
| Bosier, B; Lambert, DM; Muccioli, GG | 1 |
| Del-Bel, EA; Gomes, FV; Guimarães, FS; Issy, AC; Pedrazzi, JF | 1 |
| Chaves, YC; Crippa, JA; da Cunha, JM; de Morais, H; Genaro, K; Jesus, CHA; Waltrick, APF; Zanoveli, JM | 1 |
| Hussar, DA | 1 |
| Bortolanza, M; Crivelaro do Nascimento, G; Del Bel, EA; Ferrari, DP; Ferreira-Junior, NC; Guimaraes, FS | 1 |
| Jiang, X; Liu, XH; Shi, J; Tang, W; Wang, S; Wu, C; Xu, Y; Zha, L; Zhang, J; Zhang, Z; Zuo, J | 1 |
8 other study(ies) available for carbamates and cannabidiol
| Article | Year |
|---|---|
Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue.
Topics: Animals; Arachidonic Acids; Benzamides; Calcium; Cannabidiol; Cannabinoid Receptor Modulators; Carbamates; Cells, Cultured; Dronabinol; Endocannabinoids; Estrenes; Glutamic Acid; Glycerides; Hippocampus; Humans; Morpholines; Pertussis Toxin; Phosphodiesterase Inhibitors; Polyunsaturated Alkamides; Pyrazoles; Pyrrolidinones; Rats; Receptor, Cannabinoid, CB1; Signal Transduction | 2007 |
The effect of cannabidiol and URB597 on conditioned gaping (a model of nausea) elicited by a lithium-paired context in the rat.
Topics: Amidohydrolases; Animals; Antiemetics; Antineoplastic Agents; Benzamides; Cannabidiol; Carbamates; Conditioning, Classical; Disease Models, Animal; Dose-Response Relationship, Drug; Lithium Chloride; Male; Nausea; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Vomiting, Anticipatory | 2008 |
The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanisms.
Topics: Amidohydrolases; Animals; Animals, Outbred Strains; Anti-Anxiety Agents; Antidepressive Agents; Benzamides; Cannabidiol; Cannabinoid Receptor Antagonists; Carbamates; Cell Line, Tumor; Corpus Striatum; Dopaminergic Neurons; Endocannabinoids; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Genes, Reporter; Hippocampus; Mice; Nerve Tissue Proteins; Peroxisome Proliferator-Activated Receptors; Promoter Regions, Genetic; Receptor, Cannabinoid, CB1; Tyrosine 3-Monooxygenase | 2013 |
Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine.
Topics: Amphetamine; Animals; Benzamides; Cannabidiol; Carbamates; Inhibition, Psychological; Male; Mice; Nucleus Accumbens; Prepulse Inhibition; Reflex, Startle | 2015 |
Sub-chronic treatment with cannabidiol but not with URB597 induced a mild antidepressant-like effect in diabetic rats.
Topics: Animals; Antidepressive Agents; Benzamides; Cannabidiol; Carbamates; Depression; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Male; Rats; Rats, Wistar; Swimming | 2018 |
New Drugs 2019, part 3.
Topics: Aminoquinolines; Antibodies, Monoclonal, Humanized; Benzamides; Cannabidiol; Carbamates; Dibenzothiepins; Drug Approval; Humans; Morpholines; Oxazines; Pyridines; Pyridones; Thiepins; Triazines; United States; United States Food and Drug Administration | 2019 |
Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease.
Topics: Amidohydrolases; Analgesics; Animals; Benzamides; Brain; Cannabidiol; Capsaicin; Carbamates; Celecoxib; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Morphine; Nociception; Oxidopamine; Pain; Parkinson Disease; Piperidines; Pyrazoles; Thienamycins | 2020 |
Novel cannabidiol-carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Binding Sites; Blood-Brain Barrier; Butyrylcholinesterase; Cannabidiol; Carbamates; Cell Line, Tumor; Cell Survival; Cholinesterase Inhibitors; Drug Design; Humans; Kinetics; Maze Learning; Mice; Mice, Inbred ICR; Molecular Docking Simulation; Neuroprotective Agents; Structure-Activity Relationship | 2021 |